Medication info
Candesartan Tablets 16 mg (Candesartan Cilexetil)

Candesartan Tablets 16 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
Light yellowish-pink, round tablet with a convex shape on both sides
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201401129 · Approved 2014.03.12 · Insurance code 640902710

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment options should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Older adults: No dose adjustment is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks and increased to a maximum of 32 mg once daily, taking the patient's tolerability into account. 2) Older adults and patients with intravascular volume depletion, renal impairment, or mild to moderate hepatic impairment: No dose adjustment is necessary.
Child dose
1. Essential hypertension 6) Children: The safety and efficacy have not been established in adolescents and children 18 years of age or younger. 2. Heart failure 3) Children: The safety and efficacy have not been established in adolescents and children 18 years of age or younger.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • left ventricular systolic dysfunction
  • heart failure patients
View approved original text

This medication effectively controls blood pressure in patients with essential hypertension, reducing cardiovascular risk, and is used as an additional treatment option for heart failure patients, especially those with inadequate treatment with ACE inhibitors or those experiencing tolerance issues. It helps alleviate heart failure symptoms and improve cardiac function.

How to take

Adult dose

This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment options should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Older adults: No dose adjustment is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks and increased to a maximum of 32 mg once daily, taking the patient's tolerability into account. 2) Older adults and patients with intravascular volume depletion, renal impairment, or mild to moderate hepatic impairment: No dose adjustment is necessary.

Child dose

1. Essential hypertension 6) Children: The safety and efficacy have not been established in adolescents and children 18 years of age or younger. 2. Heart failure 3) Children: The safety and efficacy have not been established in adolescents and children 18 years of age or younger.

Precautions

This medication can cause severe harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Women who are pregnant or may become pregnant and nursing mothers should not take this medication. It should not be taken by those allergic to this drug or its components, and caution is advised for patients with severe liver disease or biliary obstruction. Patients with hereditary angioedema or a history of angioedema while taking ACE inhibitors or angiotensin II receptor antagonists should not take this medication. Patients with specific metabolic disorders such as galactose intolerance should not take this medication. Elderly patients, those with hyperkalemia, liver dysfunction, heart valve disease, ischemic heart disease, and other patients should use this medication with caution. Patients with renal impairment or renal artery stenosis and those with reduced blood volume should also use it carefully. This medication may cause side effects such as dizziness, back pain, and respiratory infections, and symptoms like fatigue, headache, and nausea have also been reported. In heart failure patients, there may be a risk of side effects such as hypotension, hyperkalemia, and deterioration of renal function, so regular blood tests are needed. In case of overdose, symptomatic hypotension and dizziness may occur, and medical assistance should be sought immediately. While taking this medication, blood pressure, renal function, and serum potassium levels should be checked regularly, and interactions with other medications should be monitored. In particular, caution should be exercised when taken with potassium-sparing diuretics or potassium supplements as the risk of hyperkalemia increases, so consultation with a healthcare provider is necessary. Care should be taken when driving or operating machinery as dizziness or drowsiness may occur. It is safest not to take this medication during pregnancy or for children and adolescents, as well as nursing mothers. This medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

  • Dizziness
  • low back pain
  • respiratory infection
  • fatigue
  • peripheral edema
  • chest pain
  • headache
  • bronchitis
  • cough
  • sinusitis
Show 59 more
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • joint pain
  • proteinuria
  • weakness
  • fever
  • sensory disturbance
  • indigestion
  • gastritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • somnolence
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • intestinal vascular edema
  • increased liver enzymes
  • hepatitis
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • renal impairment
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disorders
  • decreased libido
  • amnesia
  • decreased appetite
  • increased appetite
  • tinnitus
  • taste disturbance
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1°C and 30°C. Proper storage will help maintain the medication's effectiveness and safety for a long time.

Appearance and packaging

Appearance

Light yellowish-pink, round tablet with a convex shape on both sides

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.